All posts tagged
AstraZeneca Misses the Mark in Late-Stage Asthma Trial
More News! AstraZeneca’s €2B Blowout & First Checkpoint Inhibitor
Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?
Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation
How is Biotech Transforming Pharma’s R&D Model?
Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor
You Can Now Search Worldwide Genomic Data in a Single Platform
Can this British Biotech Overcome Failure buying drugs from AstraZeneca?
More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV
UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off
Top 5 Biologicals from European Biopharma to Launch in 2017
The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge
Labiotech UG, All Rights Reserved -
Send this to friend